Canadian Endocrinologists′ Perspectives on Treatment With Thyroid Hormone Substitutions in Euthyroid and Hypothyroid Patients: A 2023 THESIS Questionnaire Survey
Following current guidelines, LT4 tablet is the preferred treatment for hypothyroidism. Most respondents would consider triiodothyronine-containing therapy for patients with persistent symptoms, preferring LT4 + LT3 over DTE. The number of endocrinologists considering combination therapy for hypothyroid patients in Canada was higher than in Europe. Finally, at variance with current guidelines, a fraction of the respondents would consider thyroid hormones in patients with non-thyroidal conditions.
Authors
- Roberto Attanasio (ORCID: https://orcid.org/0000-0002-1417-287X)
- Petros Perros (ORCID: https://orcid.org/0000-0001-7320-5574)
- Anna Liu (ORCID: https://orcid.org/0000-0001-8752-9377)
- Enrico Papini (ORCID: https://orcid.org/0000-0003-4790-2733)
- Deric Morrison
- László Hegedüs (ORCID: https://orcid.org/0000-0002-9691-7619)
- Birte Nygaard (ORCID: https://orcid.org/0000-0002-9540-4950)
- Kamilla Ryom Riis (ORCID: https://orcid.org/0000-0003-2679-7153)
- Stan Van Uum (ORCID: https://orcid.org/0000-0002-0150-8223)
- Steen Joop Bonnema (ORCID: https://orcid.org/0000-0002-6898-1752)
- Endre Vezekenyi Nagy (ORCID: https://orcid.org/0000-0002-9286-6471)
- Roberto Negro (ORCID: https://orcid.org/0000-0001-9282-4530)
Institutions
- Western University (CA)
- University of Debrecen (HU)
- Odense University Hospital (DK)
- Herlev Hospital (DK)
- Slagelse Hospital (DK)
- Ospedale Regina Apostolorum (IT)
- Associazione Medici Diabetologi (IT)
- Ospedale Vito Fazzi (IT)
- Newcastle University (GB)
Publication Details
- Journal
- Clinical Endocrinology
- Published
- 2025-08-11
- DOI
- https://doi.org/10.1111/cen.70009
- Citations
- 1
- Primary Topic
- Thyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.29